NCT06050265View on ClinicalTrials.gov

Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary Syndrome

NARecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesDysglycemiaInsulin Resistance
Interventions
DEVICE

DEXCOM Continuous Glucose Monitor (CGM)

Dexcom CGMs are placed every 10 days and provide a continuous assessment of blood glucose.

Trial Locations (1)

94158

RECRUITING

UCSF Center for Reproductive Health, San Francisco

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER